You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prevention of COVID-19 disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19 mRNA Vaccine (ZSVG-02-O)
  • COVID-19 Vaccine (Vero Cell) ,Inactivated
  • Dengfeng, Henan, China
  • +1 more
Nov 6, 2023

Post COVID-19 Condition, Long COVID Trial in Zürich (Pycnogenol®, Placebo)

Recruiting
  • Post COVID-19 Condition
  • Long COVID
  • Zürich, Switzerland
    University of Zurich, Epidemiology, Biostatistics and Prevention
Jun 9, 2023

COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))

Recruiting
  • COVID-19
  • Recombinant new coronavirus vaccine (CHO cell)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 2, 2023

COVID-19 Trial in Nanjing (Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1)

Not yet recruiting
  • COVID-19
  • Intramuscularly administered Ad5-nCoV vaccine
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
May 10, 2023

Against SARS-CoV-2 (COVID-19)in Dazhu County in 2023

Recruiting
  • COVID-19
    • Dazhou, Sichuan, China
      Dazhu County Center for Disease Control and Prevention
    Mar 7, 2023

    COVID-19 Trial in Al Ain (AZD1222, rAd26-S)

    Completed
    • COVID-19
    • AZD1222
    • rAd26-S
    • Al Ain, United Arab Emirates
      Tawam Hospital
    Oct 24, 2022

    Fever After Vaccination, Fever, Seizures Fever Trial in United States (Pfizer-BioNTech COVID-19 Vaccine, Routine Childhood

    Not yet recruiting
    • Fever After Vaccination
    • +2 more
    • Pfizer-BioNTech COVID-19 Vaccine
    • Routine Childhood Vaccinations
    • Oakland, California
    • +4 more
    Sep 8, 2023

    COVID-19 Disease Trial in New Haven (Apilimod Dimesylate Capsule, Placebo)

    Completed
    • COVID-19 Disease
    • Apilimod Dimesylate Capsule
    • Placebo
    • New Haven, Connecticut
      Yale University
    Sep 15, 2022

    COVID-19 Trial in Changde, Changning, Zhuzhou (Omicron COVID-19 Vaccine (Vero Cell), Inactivated, COVID-19 Vaccine (Vero Cell),

    Recruiting
    • COVID-19
    • Omicron COVID-19 Vaccine (Vero Cell), Inactivated
    • COVID-19 Vaccine (Vero Cell), Inactivated
    • Changde, Hunan, China
    • +2 more
    May 30, 2022

    (PMS) for Underlying Disease at High-risk for Worsening COVID-19

    Recruiting
    • Prevention of Infectious Disease Caused by SARS-CoV-2
      • Akita, Japan
      • +9 more
      Feb 1, 2023

      COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

      Not yet recruiting
      • COVID-19
      • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
      • Placebo
      • (no location specified)
      Sep 22, 2023

      COVID-19 Trial in Tongren (Experimental vaccine 1, Experimental vaccine 2, Experimental vaccine 3)

      Suspended
      • COVID-19
      • Experimental vaccine 1
      • +2 more
      • Tongren, Guizhou, China
        Yanhe Tujia Autonomous County Center for Disease Control and Pre
      Aug 9, 2022

      COVID-19 Trial in Huai'an (COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell),

      Recruiting
      • COVID-19
      • COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
      • COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
      • Huai'an, Jiangsu, China
        Huaiyin Center for Disease Control and Prevention
      Jan 11, 2023

      Hemolysis, COVID-19 Trial in Changsha, Chengdu, Guiyang (coadministration, COVID-19 vaccine, IIV4+PPV23)

      Not yet recruiting
      • Hemolysis
      • COVID-19
      • coadministration
      • +2 more
      • Changsha, China
      • +2 more
      Aug 2, 2022

      Chinese COVID-19 Vaccines in Latin America and the Caribbean

      Not yet recruiting
      • COVID-19
        • (no location specified)
        Jul 26, 2022

        COVID-19 Pandemic Trial in China (SCTV01E, Placebo (normal saline))

        Recruiting
        • COVID-19 Pandemic
        • SCTV01E
        • Placebo (normal saline)
        • Lianshui, Jiangsu, China
        • +3 more
        Jan 5, 2023

        Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID

        Not yet recruiting
        • Influenza
        • +3 more
        • Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
        • +2 more
        • Phoenix, Arizona
        • +7 more
        Aug 30, 2023

        COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Pamplona (Nasal Photodisinfection, Sham

        Completed
        • COVID-19 Respiratory Infection
        • SARS-CoV-2 Acute Respiratory Disease
        • Nasal Photodisinfection
        • Sham Comparator: Control
        • Pamplona, Spain
          Clinica Universidad de Navarra
        Aug 10, 2022

        COVID-19 Trial in Yangchun, Zhenjiang (Experimental Group)

        Completed
        • COVID-19
        • Experimental Group
        • Yangchun, Guangdong, China
        • +1 more
        Aug 10, 2022

        COVID-19 Trial in Wuhan (Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001, ZF2001)

        Active, not recruiting
        • COVID-19
        • Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
        • ZF2001
        • Wuhan, Hubei, China
          Hubei Provincial Center for Disease Control and Prevention
        Jan 12, 2023

        COVID-19 Trial in Nanjing (low-dose LYB001, Recombinant COVID-19 Vaccine (CHO Cell), high-dose LYB001)

        Active, not recruiting
        • COVID-19
        • low-dose LYB001
        • +2 more
        • Nanjing, Jiangsu, China
          Jiangsu Provincial Center for Disease Control and Prevention
        Dec 25, 2022

        COVID-19 Trial in Nanjing (One dose group, Two doses group, Aged 18-59 years)

        Not yet recruiting
        • COVID-19
        • One dose group
        • +3 more
        • Nanjing, Jiangsu, China
          Jiangsu Provincial Center for Disease Control and Prevention
        Dec 25, 2022

        COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)

        Active, not recruiting
        • COVID-19
        • Inactivated COVID-19 Vaccine
        • Weihai, Shandong, China
          Rushan City Center for Disease Control and Prevention
        Jul 11, 2022

        COVID-19, Rabies Trial in Guiyang, Taiyuan (coadministration, COVID-19 vaccine, rabies vaccine)

        Recruiting
        • COVID-19
        • Rabies
        • coadministration
        • +2 more
        • Guiyang, China
        • +1 more
        Jul 27, 2022

        COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

        Completed
        • COVID-19
        • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
        • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
        • Taizhou, Jiangsu, China
          Taixing City center for Disease Control and Prevention
        Oct 28, 2022